News

Pharmabiz1h
Zydus Lifesciences completes 25 years of listing on NSE, commemorated with a bell ringing ceremony at NSE
Zydus Lifesciences completes 25 years of listing on NSE, commemorated with a bell ringing ceremony at NSE: Our Bureau, Mumbai ...
Pharmabiz5m
Sanofi to showcases leadership and breadth of scientific innovation in chronic inflammatory respiratory conditions at ATS conference
Sanofi to showcases leadership and breadth of scientific innovation in chronic inflammatory respiratory conditions at ATS conference: Paris Saturday, May 3, 2025, 16:00 Hrs [IST] ...
Pharmabiz4h
SunAct Advanced Cancer Therapies launches third advanced oncology centre at Dr. Gupte Hospital, Khar, Mumbai
SunAct Advanced Cancer Therapies launches third advanced oncology centre at Dr. Gupte Hospital, Khar, Mumbai: Our Bureau, ...
Pharmabiz2h
Element Science receives US FDA approval for revolutionary Jewel Patch Wearable Cardioverter Defibrillator
Element Science receives US FDA approval for revolutionary Jewel Patch Wearable Cardioverter Defibrillator: San Francisco ...
Pharmabiz1h
Nexalin Technology initiates US FDA Q-Submission process for Gen-2 SYNC system
Nexalin Technology initiates US FDA Q-Submission process for Gen-2 SYNC system: Houston, Texas Saturday, May 3, 2025, 15:00 Hrs [IST] Nexalin Technology, Inc., a company designs a ...
Pharmabiz4h
Bavarian Nordic receives UK MHRA marketing authorization for chikungunya vaccine, Vimkunya for persons aged 12 and older
Copenhagen, Denmark Saturday, May 3, 2025, 12:00 Hrs [IST] ...
Pharmabiz3h
Repare Therapeutics out-licenses discovery platforms to DCx Biotherapeutics
Repare Therapeutics out-licenses discovery platforms to DCx Biotherapeutics: Cambridge, Massachusetts Saturday, May 3, 2025, 13:00 Hrs [IST] Repare Therapeutics Inc. (Repare), a l ...
Pharmabiz6h
AstraZeneca’s fixed-dose triple-combination therapy, Breztri meets primary endpoints in KALOS & LOGOS phase III trials in asthma
AstraZeneca’s fixed-dose triple-combination therapy, Breztri meets primary endpoints in KALOS & LOGOS phase III trials in asthma: Cambridge, UK Saturday, May 3, 2025, 10:00 Hrs ...
Pharmabiz7h
University of East Anglia uses MRI to detect ageing heart
University of East Anglia (UEA) scientists have developed a revolutionary new way of uncovering the ‘true age’ of your heart using MRI. Research published shows how an MRI scan can reveal your heart’s ...
Pharmabiz5h
Illumina & Ovation.io launch first-of-kind GLP-1 dataset to accelerate new therapy development
Illumina & Ovation.io launch first-of-kind GLP-1 dataset to accelerate new therapy development: San Diego Saturday, May 3, 2025, 11:00 Hrs [IST] Illumina, Inc., and Ovation.io, In ...
Pharmabiz8h
India’s Healthtech boom faces tough test to balance personalisation and data privacy: Vineet Mehta
India’s Healthtech boom faces tough test to balance personalisation and data privacy: Vineet Mehta: Shardul Nautiyal, Mumbai Saturday, May 3, 2025, 08:00 Hrs [IST] In India, hea ...
Pharmabiz8h
DGFT eases pharma export rules for SCOMET items for testing and evaluation
DGFT eases pharma export rules for SCOMET items for testing and evaluation: Shardul Nautiyal, Mumbai Saturday, May 3, 2025, 08:00 Hrs [IST] In a move to facilitate technological a ...